Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 11148402!ä!11148402 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Mal+Vasc 2000 ; 25 (5): 382-387 Nephropedia Template TP {{tp|p=11148402|t=2000. Devant quelles manifestations vasculaires rechercher un syndrome myeloproliferatif?|pdf=|usr=}}{{11148402}} gab.com Text Devant quelles manifestations vasculaires rechercher un syndrome myeloproliferatif JO: J Mal Vasc http://www.kidney.de/pget.php?&tw=1&pmid=11148402 #FOAvip Patients with polycethemia vera (PV) or essential thrombocythemia (ET) are at increased risk of arterial and venous thromboembolic events. Arterial ischemic complications occur in 24 to 43% of these patients, particularly those with cardiovascular risk factors (especially cigarette smoking). Non-atheromatous arterial thrombosis concerns all large and medium-sized vessels, particularly cerebral, limb, coronary and digestive arteries. Extensive complications have been described in patients with lower limb occlusive arteriopathy, particularly stent or bypass thrombosis, critical ischemia. Juvenile myocardial infarction or rapid postangioplasty coronary thrombosis may reveal certain myeloproliferative disorders, particularly ET. Venous thrombosis is more frequent in PV than in ET; superficial or deep venous thromboses are seen. Thromboembolic events occur in about 25-30% of the patients and account for one-third of the deaths. Mesenteric vein thrombosis, portal thrombosis, or suprahepatic vein thrombosis may occur in all myeloproliferative disorders, but the pathogenesis is not fully understood. Pulmonary hypertension may be the consequence of local thrombosis in the pulmonary vasculature or may be due to the high blood flow in the right heart cavities. Microvascular circulatory disturbance includes erythromelalgia, Raynaud's phenomenon, digital ischemia, acrocyanosis, blue toe syndrome, livedo reticularis, cutaneous ulcers or necrotic purpura. All these manifestations may precede the myeloproliferative disorder by several months. Twit Text FOAVip Devant quelles manifestations vasculaires rechercher un syndrome myeloproliferatif ????J Mal Vasc http://www.kidney.de/pget.php?&tw=1&pmid=11148402 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=11148402 #FOAvip English Wikipedia <ref>{{Cite pmid|11148402}}</ref> Devant quelles manifestations vasculaires rechercher un syndrome myeloproliferatif? #MMPMID11148402 Hachulla E; Rose C; Trillot N; Caulier-Leleu MT; Pasturel-Michon U J Mal Vasc 2000[Dec]; 25 (5): 382-387 PMID11148402show ga Patients with polycethemia vera (PV) or essential thrombocythemia (ET) are at increased risk of arterial and venous thromboembolic events. Arterial ischemic complications occur in 24 to 43% of these patients, particularly those with cardiovascular risk factors (especially cigarette smoking). Non-atheromatous arterial thrombosis concerns all large and medium-sized vessels, particularly cerebral, limb, coronary and digestive arteries. Extensive complications have been described in patients with lower limb occlusive arteriopathy, particularly stent or bypass thrombosis, critical ischemia. Juvenile myocardial infarction or rapid postangioplasty coronary thrombosis may reveal certain myeloproliferative disorders, particularly ET. Venous thrombosis is more frequent in PV than in ET; superficial or deep venous thromboses are seen. Thromboembolic events occur in about 25-30% of the patients and account for one-third of the deaths. Mesenteric vein thrombosis, portal thrombosis, or suprahepatic vein thrombosis may occur in all myeloproliferative disorders, but the pathogenesis is not fully understood. Pulmonary hypertension may be the consequence of local thrombosis in the pulmonary vasculature or may be due to the high blood flow in the right heart cavities. Microvascular circulatory disturbance includes erythromelalgia, Raynaud's phenomenon, digital ischemia, acrocyanosis, blue toe syndrome, livedo reticularis, cutaneous ulcers or necrotic purpura. All these manifestations may precede the myeloproliferative disorder by several months. |Adult[MESH] |Aged[MESH] |Alkylating Agents/adverse effects/therapeutic use[MESH] |Arterial Occlusive Diseases/etiology[MESH] |Cross-Sectional Studies[MESH] |Erythromelalgia/etiology[MESH] |Female[MESH] |Hemorrhage/etiology[MESH] |Humans[MESH] |Hydroxyurea/adverse effects/therapeutic use[MESH] |Hypertension, Pulmonary/etiology[MESH] |Ischemia/*etiology[MESH] |Male[MESH] |Microcirculation[MESH] |Middle Aged[MESH] |Myeloproliferative Disorders/complications/*diagnosis[MESH] |Myocardial Infarction/etiology[MESH] |Pain/etiology[MESH] |Polycythemia Vera/complications/diagnosis[MESH] |Purpura/etiology[MESH] |Skin Ulcer/chemically induced/etiology[MESH] |Smoking/adverse effects[MESH] |Stroke/etiology[MESH] |Thrombocythemia, Essential/complications/diagnosis/drug therapy[MESH] |Thrombophilia/*etiology[MESH]Devant quelles manifestations vasculaires rechercher un syndrome myel(epmc).pdf DeepDyve Pubget Overpricing